Overview Cell and Gene Therapies are revolutionary approaches in treating diseases at their roots. These therapies work by either modifying genes (gene therapy) or manipulating cells (cell therapy), often combining both methods—for instance, gene‐modified cell therapies like CAR‑T, where a patient’s T cells are genetically engineered to target cancer cells. The market includes...

"Executive Summary Hereditary Cancer Testing Market : CAGR Value Data Bridge Market Research analyzes that the global hereditary cancer testing market is expected to reach the value of USD 13,085.04 million by 2029, at a CAGR of 12.9% during the forecast period. This market report also covers pricing analysis, patent analysis, and technological advancements in depth. The Hereditary...

Executive Summary Hemato Oncology Testing Market Size and Share: Global Industry Snapshot CAGR Value The global hemato oncology testing market was valued at USD 8.13 billion in 2024 and is expected to reach USD 14.83 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers...

"Executive Summary Laboratory-Developed Tests (LDTs) Market Research: Share and Size Intelligence CAGR Value The global laboratory-developed tests (LDTs) market size was valued at USD 13.42 billion in 2024 and is expected to reach USD 30.28 billion by 2032, at a CAGR of 10.70% during the forecast period Market research studies stated in this Laboratory-Developed Tests (LDTs)...

The Ulcerative Colitis Market is experiencing accelerated growth as personalized medicine becomes a central theme in healthcare. Physicians are shifting from traditional, generalized treatment regimens toward individualized approaches that consider genetic, environmental, and lifestyle factors. This transition is supported by precision diagnostics, biomarker identification, and...